Preventability of Hospital Deaths in Patients with Non-Ventilator Hospital-Acquired Pneumonia.

Alexander M TataraAnna ApostolopoulouAnna A AganLaura DelloStrittoChanu RheeMichael Klompas

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)

Most patients who die following NV-HAP have multiple, severe underlying comorbidities and difficult-to-modify risk factors for NV-HAP. Only 1 in 5 NV-HAPs that culminated in death and 1 in 12 deaths following NV-HAP were judged potentially preventable. This does not diminish the importance of NV-HAP prevention programs but informs expectations about the potential magnitude of their impact on hospital deaths.

Keyphrases

adverse drug
healthcare
acute care
risk assessment
intensive care unit
acute respiratory distress syndrome
climate change
drug induced
community acquired pneumonia